Morgan Stanley’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.1M | Buy |
433,508
+94,705
| +28% | +$3.41M | ﹤0.01% | 3091 |
|
|
2026
Q1 | $8.31M | Sell |
338,803
-95,022
| -22% | -$2.25M | ﹤0.01% | 3721 |
|
|
2025
Q4 | $10.8M | Sell |
433,825
-64,042
| -13% | -$1.7M | ﹤0.01% | 3547 |
|
|
2025
Q3 | $14.1M | Sell |
497,867
-10,495
| -2% | -$284K | ﹤0.01% | 3231 |
|
|
2025
Q2 | $12.6M | Buy |
508,362
+165,053
| +48% | +$4.65M | ﹤0.01% | 3226 |
|
|
2025
Q1 | $10.6M | Sell |
343,309
-69,111
| -17% | -$2.3M | ﹤0.01% | 3278 |
|
|
2024
Q4 | $13M | Buy |
412,420
+69,834
| +20% | +$3.32M | ﹤0.01% | 3160 |
|
|
2024
Q3 | $19.8M | Buy |
342,586
+4,650
| +1% | +$228K | ﹤0.01% | 2814 |
|
|
2024
Q2 | $13.7M | Sell |
337,936
-33,018
| -9% | -$1.31M | ﹤0.01% | 3060 |
|
|
2024
Q1 | $15.6M | Sell |
370,954
-20,245
| -5% | -$790K | ﹤0.01% | 2957 |
|
|
2023
Q4 | $15M | Buy |
391,199
+111,202
| +40% | +$3.7M | ﹤0.01% | 2975 |
|
|
2023
Q3 | $8.64M | Buy |
279,997
+18,110
| +7% | +$625K | ﹤0.01% | 3262 |
|
|
2023
Q2 | $8.28M | Sell |
261,887
-2,226
| -0.8% | -$76.3K | ﹤0.01% | 3344 |
|
|
2023
Q1 | $9.63M | Buy |
264,113
+19,351
| +8% | +$677K | ﹤0.01% | 3181 |
|
|
2022
Q4 | $7.24M | Sell |
244,762
-118,311
| -33% | -$3.8M | ﹤0.01% | 3393 |
|
|
2022
Q3 | $14.2M | Buy |
363,073
+153,996
| +74% | +$7.05M | ﹤0.01% | 2583 |
|
|
2022
Q2 | $8.07M | Sell |
209,077
-23,764
| -10% | -$904K | ﹤0.01% | 3294 |
|
|
2022
Q1 | $11.3M | Buy |
232,841
+65,493
| +39% | +$3.38M | ﹤0.01% | 2775 |
|
|
2021
Q4 | $12.3M | Buy |
167,348
+39,014
| +30% | +$3.21M | ﹤0.01% | 2707 |
|
|
2021
Q3 | $11.7M | Buy |
128,334
+30,440
| +31% | +$2.59M | ﹤0.01% | 2708 |
|
|
2021
Q2 | $6.15M | Buy |
97,894
+58,490
| +148% | +$2.16M | ﹤0.01% | 3566 |
|
|
2021
Q1 | $1.07M | Buy |
39,404
+5,864
| +17% | +$141K | ﹤0.01% | 4689 |
|
|
2020
Q4 | $613K | Buy |
33,540
+28,383
| +550% | +$510K | ﹤0.01% | 4949 |
|
|
2020
Q3 | $92K | Sell |
5,157
-755
| -13% | -$13K | ﹤0.01% | 5462 |
|
|
2020
Q2 | $98K | Buy |
5,912
+4,858
| +461% | +$76.4K | ﹤0.01% | 5410 |
|
|
2020
Q1 | $13K | Sell |
1,054
-7,612
| -88% | -$124K | ﹤0.01% | 5961 |
|
|
2019
Q4 | $160K | Buy |
8,666
+1,040
| +14% | +$17.2K | ﹤0.01% | 5495 |
|
|
2019
Q3 | $134K | Buy |
7,626
+7,308
| +2,298% | +$125K | ﹤0.01% | 5334 |
|
|
2019
Q2 | $5K | Sell |
318
-1,433
| -82% | -$26K | ﹤0.01% | 6321 |
|
|
2019
Q1 | $32K | Sell |
1,751
-4,769
| -73% | -$91.5K | ﹤0.01% | 5855 |
|
|
2018
Q4 | $129K | Sell |
6,520
-4,222
| -39% | -$79K | ﹤0.01% | 5448 |
|
|
2018
Q3 | $238K | Sell |
10,742
-45,706
| -81% | -$962K | ﹤0.01% | 5369 |
|
|
2018
Q2 | $1.46M | Buy |
56,448
+34,583
| +158% | +$593K | ﹤0.01% | 4349 |
|
|
2018
Q1 | $349K | Buy |
21,865
+15,891
| +266% | +$329K | ﹤0.01% | 5196 |
|
|
2017
Q4 | $143K | Buy |
+5,974
| New | +$120K | ﹤0.01% | 5528 |
|
Other funds holding ASTH
3C
Morgan Stanley's ASTH Position: Q2 2026 in Review
Morgan Stanley increased its Astrana Health (ASTH) stake by 28% in Q2 2026, buying an estimated $3.41M and bringing the position to 433,508 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3091.
Morgan Stanley first reported a position in ASTH in Q4 2017 and has held it in 35 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Morgan Stanley held 433,508 shares of Astrana Health worth $20.1M as of Q2 2026.
- Morgan Stanley bought 94,705 Astrana Health shares in Q2 2026, an estimated $3.41M.
- Astrana Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3091 holding.
- Morgan Stanley first reported a position in Astrana Health in Q4 2017 and has held it in 35 quarters since.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.